CIK 0001599298
- Large accelerated filer
Summit Therapeutics Inc.
Sign in to watch- Ticker
- SMMT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 371979717
- Phone
- +1 305-203-2034
- Business address
- 601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL, 33131
- Former names
- Summit Therapeutics plc, Summit Corp plc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-30 | Powell David Jonathan Chief Scientific Officer | Exercise or conversion | +13,713 | $1.79 | $25K | 13,713 |
| 2020-11-30 | Powell David Jonathan Chief Scientific Officer | Sale | −13,713 | $4.44 | $61K | 0 |
| 2020-11-30 | Powell David Jonathan Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −13,713 | $1.79 | $25K | 390,973 |
| 2020-11-27 | Powell David Jonathan Chief Scientific Officer | Exercise or conversion | +16,616 | $1.92 | $32K | 16,616 |
| 2020-11-27 | Powell David Jonathan Chief Scientific Officer | Exercise or conversion | +12,953 | $1.79 | $23K | 29,569 |
| 2020-11-27 | Powell David Jonathan Chief Scientific Officer | Sale | −29,569 | $4.39 | $130K | 0 |
| 2020-11-27 | Powell David Jonathan Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −16,616 | $1.92 | $32K | 417,639 |
| 2020-11-27 | Powell David Jonathan Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −12,953 | $1.79 | $23K | 404,686 |
| 2020-11-25 | Powell David Jonathan Chief Scientific Officer | Exercise or conversion | +12,070 | $1.92 | $23K | 12,070 |
| 2020-11-25 | Powell David Jonathan Chief Scientific Officer | Sale | −12,070 | $4.32 | $52K | 0 |
| 2020-11-25 | Powell David Jonathan Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −12,070 | $1.92 | $23K | 434,255 |
| 2020-11-24 | Powell David Jonathan Chief Scientific Officer | Exercise or conversion | +11,374 | $1.92 | $22K | 11,374 |
| 2020-11-24 | Powell David Jonathan Chief Scientific Officer | Sale | −11,374 | $4.21 | $48K | 0 |
| 2020-11-24 | Powell David Jonathan Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −11,374 | $1.92 | $22K | 446,325 |
| 2020-11-23 | Powell David Jonathan Chief Scientific Officer | Exercise or conversion | +6,987 | $1.92 | $13K | 6,987 |
| 2020-11-23 | Powell David Jonathan Chief Scientific Officer | Sale | −6,987 | $4.40 | $31K | 0 |
| 2020-11-23 | Powell David Jonathan Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −6,987 | $1.92 | $13K | 457,699 |
Page 1 of 1 · 17 trades